Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Xiong Pei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Bone Density, Mendelian Randomization Analysis, Genome-Wide Association Study. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Background
Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have a higher risk of osteoporosis/fractures; however, the causal relationship remains unclear.
Methods
Publicly available genome‐wide association studies (GWASs) were used for Mendelian randomization (MR) analysis. GWASs of NAFLD and fractures were obtained from the FinnGen Consortium. GWASs of bone mineral density (BMD) were derived from a meta‐analysis. GWASs of obesity, diabetes, liver function, and serum lipid‐related metrics were used to clarify whether the accompanying NAFLD symptoms contributed to fractures. Moreover, two additional GWASs of NAFLD were applied.
Results
A causal association was not observed between NAFLD and BMD using GWASs from the FinnGen Consortium. However, a causal relationship between NAFLD and femoral neck‐BMD (FN‐BMD), a suggestive relationship between fibrosis and FN‐BMD, and between NAFLD and osteoporosis were identified in replication GWASs. Genetically proxied body mass index (BMI), high‐density lipoprotein (HDL), and hip circumference increased the likelihood of lower limb fractures. The waist‐to‐hip ratio decreased, whereas glycated hemoglobin (HbA1C) and homeostasis model assessment of β‐cell function (HOMA‐B) increased the risk of forearm fractures. Low‐density lipoprotein (LDL) reduced, whereas HbA1C increased the incidence of femoral fractures. Alkaline phosphatase (ALP) raised the risk of foot fractures. However, after a multivariate MR analysis (adjusted for BMI), all the relationships became insignificant.
Conclusions
NAFLD caused reduced BMD, and genetically predicted HDL, LDL, HbA1C, HOMA‐B, ALP, hip circumference, and waist‐to‐hip ratio causally increased the risk of fractures. BMI may mediate causal relationships. Larger GWASs are required to verify this finding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
ORCID-Profile: Ming Wang, Enqiang Chen, Hong Tang, Dongbo Wu
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Pei, X., Jiang, W., Li, L., Zeng, Q., Liu, C. H., Wang, M., Chen, E., Zhou, T., Tang, H., & Wu, D. (2024). Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16448
Vancouver
Pei X, Jiang W, Li L, Zeng Q, Liu CH, Wang M, et al. Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16448
BibTeX
@article{Pei2024,
author = {Pei, Xiong and Jiang, Wei and Li, Lianchi and Zeng, Qingmin and Liu, Chang-Hai and Wang, Ming and Chen, Enqiang and Zhou, Taoyou and Tang, Hong and Wu, Dongbo},
title = {Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16448}
}
EUVIMED